Mary Kay Fenton, SVP and CFO at ACHILLION PHARMACEUTICALS INC (ACHN), sold 4,000 shares at $7.50 ($30K) on 2011-03-30, disclosed to the SEC on 2011-04-01.
Scheduled sale ($30k) by SVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACHN | SELL | 2015-12-30 | $438K | — | Filing → |
| ACHN | SELL | 2015-01-23 | $210K | — | Filing → |
| ACHN | SELL | 2012-01-11 | $168K | — | Filing → |